Boston Childrenâ€™s Hospital Claims Puberty Blockers â€˜Completely Reversibleâ€™; Director Admits They Cause Infertility During Use

The Boston Childrenâ€™s Hospital claims that puberty-blocking drugs are â€œcompletely reversibleâ€ although during use, they stop sperm and egg production, according to the director of their gender clinic in a video obtained by Breitbart News.

It goes on to claim that â€œThese are temporary medicines that are completely reversible; they do not cause any permanent changes.â€

Despite being the director of the clinic, Carswell was unable to answer an audience member when she was asked whether or not the administration of puberty-blocking drugs could result in an inability to orgasm.

Carswell has also claimed on camera that children might know that they are transgender â€œfrom the minute they were born, practically.â€ She also cited â€œplaying with opposite gender toysâ€ as a sign that a child should be considered transgender.

â€œPlaying with the opposite gender toysâ€ is a sign your child is transgender.

Thatâ€™s exactly what Boston Childrenâ€™s Hospital says. pic.twitter.com/pYXV0kdSBi

â€” Billboard Chris ğŸ‡ºğŸ‡¸ (@BillboardChris) August 13, 2022

Carswell received $3,055 from Endo Pharmaceuticals in 2018, the most recent year for which data is available. Endo Pharmaceuticals manufactures Supprelin LA, which is used off-label as a puberty blocker.

An article co-written by Carswell titled â€œPubertal suppression for transgender youth and risk of suicidal ideationâ€ had to be corrected after it claimed the authors had no potentially conflicting interests. The article was corrected to note that Carswell â€œhas received an advisory board stipend from Endo Pharmaceuticals.â€

In a different article titled â€œAddressing Legislation That Restricts Access To Care For Transgender Youth,â€ the conflict of interest statement notes that â€œDr. Carswell previously served as a consultant to Endo Pharmaceuticals in June 2018.â€

This report is part of an ongoing investigation from Breitbart News exploring the links and incentives between pro-transgender activism, pharmaceutical companies, and other medical interests.

Spencer Lindquist is a reporter for Breitbart News. Follow him on Twitter @SpencerLndqst and reach out at slindquist@breitbart.com.

Please let us know if you're having issues with commenting.

